ADMA Biologics
- Market cap
- 2.27B
- P/E (TTM)i
- 14.49
- P/Bi
- 5.57
- EPSi
- 0.60
- Div yieldi
- 0.00%
- 52W posi
- 22%
Anonymous reader poll. Unscientific, not investment advice.
ADMA Biologics shares were changing hands at 10.14, down 0.39% on the day. The company carries a market value of roughly 2.27B, the #2705 most valuable US-listed company we track. Wall Street's 3-analyst consensus lands on Buy, with a price target averaging 15.67 (+55% from here). Against a 52-week band of 7.21-20.46, the shares are currently 22% of the way up.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average and near the bottom of the universe on momentum.
- Signal has read STRONG SELL for 7 months.
- Its last 3 Sell calls were actually followed by a +11% average gain three months out - this one has bounced back faster than the signal expected.
- Recent price momentum is -8.7% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 10.8% of float.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 10.18
- Open
- 10.15
- Day range
- 10.07 - 10.32
- Avg price
- 10.18
- Volume
- 3.05M
- Turnover
- 31.04M
- Turnover ratei
- 1.39%
- Volume ratioi
- 1.01
- Amplitudei
- 2.46%
- 52-week rangei
- 7.21 - 20.46
Valuation
- P/Ei
- 16.90
- P/E (TTM)i
- 14.49
- P/Bi
- 5.57
- EPSi
- 0.60
- Book value / shi
- 1.82
- Net profit
- 134.39M
- Net assets
- 408.10M
Share structure
- Market cap
- 2.27B
- Float capi
- 2.23B
- Shares out
- 223.98M
- Float sharesi
- 219.66M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
50.4% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-4.17M net over the window
Short interest
- Shares short
- 24.21M
- % of floati
- 10.81%
- Days to coveri
- 10.81
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of ADMA Biologics (ADMA)?
ADMA Biologics last traded at 10.14. The quote on this page refreshes every few seconds while US markets are open.
What is ADMA Biologics's market cap?
About 2.27B.
What is the P/E ratio of ADMA Biologics?
The trailing twelve-month P/E is 14.49. The Valuation tab shows it against the stock's own five-year range.
Does ADMA Biologics pay a dividend?
ADMA Biologics does not currently pay a regular dividend.
Is ADMA Biologics a buy according to analysts?
The consensus of 3 analysts is a Buy rating, with an average 12-month price target of 15.67, which implies 54.5% upside from the current price. This is not investment advice.
What is ADMA Biologics's StockVane Quant Rating?
The StockVane Momentum strategy currently rates ADMA Biologics a E (Strong Sell). Below its 200-day average and near the bottom of the universe on momentum. Not investment advice.
Quote time 2026-10-08 06:48:57 · For reference only, not investment advice and not tailored to your situation.